Teva Pharmaceuticals USA

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Teva Pharmaceuticals USA sits in the top decile of US sponsors by registered trial count (#271 of 15,751 sponsors by registered trial count).

83 total trials none currently recruiting 81 completed early-phase tilt top decile by trial count

Teva Pharmaceuticals USA: 83 sponsored US clinical trials, none currently recruiting.

Teva Pharmaceuticals USA sponsors 83 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 81 completed. 7 of these trials are in Phase 3-4 (later-stage) and 76 in Phase 1-2 (earlier-stage).

Top-decile sponsor footprint

Teva Pharmaceuticals USA ranks in the top decile of sponsors by registered trial count (#271 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

83 total, page 2 of 2

COMPLETED Phase 1

Ribavirin 200 mg Tablets Under Non-Fasting Conditions

NCT00835536
COMPLETED Phase 1

Cefprozil 500 mg Tablets Under Fed Conditions

NCT00840866
COMPLETED Phase 1

Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions

NCT00834639
COMPLETED Phase 1

Ribavirin 200 mg Tablets Under Fasting Conditions

NCT00835146
COMPLETED Phase 1

Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions

NCT00834990
COMPLETED Phase 1

Lansoprazole 30 mg DR Capsule Replicate Food Study

NCT01046084
COMPLETED Phase 1

15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting

NCT00834197
COMPLETED Phase 1

15 mg Mirtazapine Orally Disintegrating Tablets, Fasting

NCT00835575
COMPLETED Phase 1

Mesalamine 4 gm/60 mL Rectal Enema

NCT00840203
COMPLETED Phase 1

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

NCT00835172
COMPLETED Phase 1

Glimepiride 4 mg Tablets Under Fasting Conditions

NCT00834340
COMPLETED Phase 1

Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

NCT00934921
COMPLETED Phase 1

Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions

NCT00934180
COMPLETED Phase 1

Clarithromycin 500 mg Tablets Under Fasting Conditions

NCT00835692
COMPLETED Phase 1

Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

NCT00836706
COMPLETED Phase 1

Leflunomide 20 mg Tablets Under Fasting Conditions

NCT00834418
COMPLETED Phase 1

Finasteride 5 mg Tablets Under Fasting Conditions

NCT00835666
COMPLETED Phase 1

Finasteride 5 mg Tablets, Non-fasting

NCT00835796
COMPLETED Phase 1

Leflunomide 20 mg Tablets, Non-Fasting

NCT00834405
COMPLETED Phase 1

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

NCT00833937
COMPLETED Phase 1

Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

NCT00833521
COMPLETED Phase 1

Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions

NCT00835640
COMPLETED Phase 1

Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

NCT01020396
COMPLETED Phase 1

Terbinafine HCl 250 mg Tablet Under Fasting Conditions

NCT00833586
COMPLETED Phase 1

Buspirone Hydrochloride 30mg Tablets, Non-Fasting

NCT00840398
COMPLETED Phase 1

Buspirone Hydrochloride 30mg Tablets, Fasting

NCT00840606
COMPLETED Phase 1

Carvedilol (25 mg) in 24 Fed, Healthy, Adult Subjects

NCT00834873
COMPLETED Phase 1

Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects

NCT00834795
COMPLETED Phase 1

Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects

NCT01020877
COMPLETED Phase 1

90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

NCT01247285
COMPLETED Phase 1

90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions

NCT01247272
COMPLETED Phase 1

Benazepril HCl 40 mg Tablets, Fed

NCT00836537
COMPLETED Phase 1

Benazepril HCl 40 mg Tablets, Fasting

NCT00836576
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 76
Phase 3 7

How the Teva Pharmaceuticals USA early-phase archive is shaped

83 indexed studies, none listed as recruiting (0% open); 81 completed (98%).

Phase mix: 7 late (III/IV) vs 76 early (I/II) (early-phase heavy).

Therapeutic area indexing for this sponsor is limited in the public registry.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.